In vivo pharmacological actions of F 11356, a novel high efficacy anti-migraine 5-HT1B/D receptor agonist.

被引：0
|
作者：
John, GW [1 ]
Verscheure, Y [1 ]
Infanti, F [1 ]
Bel, L [1 ]
Perez, M [1 ]
Halazy, S [1 ]
Chopin, P [1 ]
Marien, M [1 ]
Colpaert, FC [1 ]
机构：
[1] Ctr Rech Pierre Fabre, F-81106 Castres, France
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P5261
引用
收藏
页码：R523 / R523
页数：1
相关论文
共 50 条
  • [41] 311C90 ('Zomig', or zolmitriptan), a novel 5-HT1B/1D agonist for treatment of acute migraine: Mechanism of action
    Martin, GR
    Goadsby, PJ
    NEUROLOGY, 1997, 48 (03) : 1131 - 1131
  • [42] Pharmacological analysis of 5-HT-receptor-mediated vasoconstriction of human middle meningeal arteries: Determining the contribution of 5-HT1B and 5-HT1F receptor activation
    Razzaque, Z
    Shaw, D
    Smith, D
    Hopkins, R
    Sirinathsinghji, D
    Maskell, L
    Stanton, JA
    Beer, MS
    Hill, RG
    Pickard, J
    Longmore, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P211 - P211
  • [43] 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists:: Potential treatments for migraine
    Meng, CQ
    Rakhit, S
    Lee, DKH
    Kambo, R
    McCallum, KL
    Mazzocco, L
    Dyne, K
    Slassi, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) : 903 - 905
  • [44] Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT1F-G protein complex
    Huang, Sijie
    Xu, Peiyu
    Tan, Yangxia
    You, Chongzhao
    Zhang, Yumu
    Jiang, Yi
    Xu, H. Eric
    CELL RESEARCH, 2021, 31 (09) : 1036 - 1038
  • [45] Structural basis for recognition of anti-migraine drug lasmiditan by the serotonin receptor 5-HT1F–G protein complex
    Sijie Huang
    Peiyu Xu
    Yangxia Tan
    Chongzhao You
    Yumu Zhang
    Yi Jiang
    H. Eric Xu
    Cell Research, 2021, 31 : 1036 - 1038
  • [46] The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine
    Reuter, Uwe
    Israel, Heike
    Neeb, Lars
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 46 - 54
  • [47] Serotonin 5-HT1B/1D receptor agonists in migraine -: Comparative pharmacology and its therapeutic implications
    Goadsby, PJ
    CNS DRUGS, 1998, 10 (04) : 271 - 286
  • [48] The 5-HT1B/D receptor agonist naratriptan microinjected into the periaqueductal grey selectively inhibits meningeal nociception
    Bartsch, T
    Knight, YE
    Goadsby, PJ
    CEPHALALGIA, 2003, 23 (07) : 650 - 650
  • [49] NXN-188, a selective nNOS inhibitor and a 5-HT1B/1D receptor agonist, inhibits CGRP release in preclinical migraine models
    Bhatt, Deepak K.
    Gupta, Saurabh
    Jansen-Olesen, Inger
    Andrews, John S.
    Olesen, Jes
    CEPHALALGIA, 2013, 33 (02) : 87 - 100
  • [50] Effects of a selective 5-HT1B/1D receptor agonist on spinal and trigeminal reflexes in the anaesthetized rabbit
    Jenkins, S
    Richardson, B
    Clarke, RW
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 (05) : 974 - 980
12345